Cover Image

Efficacy and Safety of Keverprazan–Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Shanshan Wei, Zhihao Huang, Huizhen Xiong, Ji Wu, Dihua Mei, Jing Zhao, Wei Liu, Qingyun Liu, Yu Lin, Fang Liu, Xiang Peng, Honglei Chen
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Helicobacter
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of Three Amoxicillin Doses in Vonoprazan Dual Therapy for Helicobacter pylori Eradication: A Randomized Noninferiority Trial
by: Ruolin Peng, et al.
Published: (2025)

Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China
by: Xueyan Lin, et al.
Published: (2024)

Vonoprazan–Amoxicillin Dual Therapy With Different Amoxicillin Administration Regimens for Helicobacter pylori Treatment: A Randomized Controlled Trial
by: Shuhan Qiu, et al.
Published: (2024)

Optimizing Duration and Dosing Frequency of Vonoprazan–Amoxicillin Dual Therapy for Helicobacter pylori: A Multicenter Randomized Trial
by: Lulong Tao, et al.
Published: (2025)

Efficacy and Safety of Vonoprazan‐Based Dual, Triple, and Quadruple Therapies for Helicobacter pylori Eradication: A Randomized Controlled Trial
by: Jin‐Yan Zhang, et al.
Published: (2026)

Helicobacter pylori Infection in Children: To Eradicate or Not to Eradicate?
by: Marco Manfredi, et al.
Published: (2024)

Fourteen‐Day Tegoprazan–Amoxicillin Dual Therapy as the First‐Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical Trial
by: Qingzhou Kong, et al.
Published: (2024)

Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial
by: Jae Yong Park, et al.
Published: (2026)

Correction to “Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial”
Published: (2026)

Efficacy and Safety of Vonoprazan‐Based Dual Therapies With Different Antibiotics Versus Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Prospective, Four‐Arm, Randomized Controlled Trial
by: Jie Li, et al.
Published: (2026)

Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First‐Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta‐Analysis
by: Belén Martínez Benito, et al.
Published: (2024)

Vonoprazan Improves Efficacy of Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter Randomized Controlled Trial
by: Tian‐Lian Yan, et al.
Published: (2025)

Letter to the Editor: “Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential Analysis”
by: Ben‐Gang Zhou, et al.
Published: (2025)

Efficacy and Safety of Levofloxacin‐ Versus Moxifloxacin‐Based Nitazoxanide Quadruple Therapy as Second‐Line Treatment for Helicobacter pylori in Egypt: A Randomized Multicenter Trial
by: Gasser El‐Azab, et al.
Published: (2026)

Reevaluating the Adverse Events With the Same‐Dosage Regimen in Hemodialysis Patients Undergoing Helicobacter pylori Eradication
by: Keigo Misawa, et al.
Published: (2025)

Comparison of Cefuroxime‐Based Dual Therapy With Quadruple Therapy in Helicobacter pylori‐Infected Treatment‐Naive Patients: A Prospective, Multicenter, Randomized Controlled Trial
by: Ji‐Yan Li, et al.
Published: (2025)

Letter to the Editor: Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential Analysis—Authors' Reply
by: Vivek Mishra, et al.
Published: (2025)

Interpretation the Results of Eradicating Helicobacter pylori Infection Causing Colorectal Cancer Could Be Cautious
by: Lo‐Yip Yu, et al.
Published: (2025)

Efficacy of Bismuth Therapy in Eradicating Helicobacter pylori in Children—Data From the RENIHp Registry
by: Gonzalo Botija, et al.
Published: (2024)

Seven‐Day Versus 14‐Day Tegoprazan and Tetracycline‐Containing Quadruple Therapy for First‐Line Eradication of Helicobacter pylori Infection: A Randomized, Open‐Label, Noninferiority Trial
by: Xue‐Ping Nan, et al.
Published: (2025)

Eradication Rates of Empiric Helicobacter pylori Treatment Regimens by Race/Ethnicity in a Predominantly Immigrant U.S. Population
by: Min J. Kim, et al.
Published: (2025)

Efficacy of Tetracycline Three Times Daily was Comparable to That of Four Times Daily for Helicobacter pylori Rescue Treatment: A Multicenter, Noninferiority, Randomized Controlled Trial
by: Zhongxue Han, et al.
Published: (2024)

EUROHELICAN —Accelerating Gastric Cancer Reduction Through Helicobacter pylori Eradication
by: Bojan Tepeš, et al.
Published: (2026)

Tetracycline Three Times Daily Versus Four Times Daily in Bismuth‐Containing Quadruple Therapy as the First‐Line Treatment of Helicobacter pylori Infection: A Multicenter, Noninferiority, Randomized Controlled Trial
by: Yu‐Ming Ding, et al.
Published: (2024)

Exploration of a Potential Amoxicillin MIC Threshold in Bismuth Quadruple Therapy for H. pylori Infection in Southeastern China
by: Ding Lu, et al.
Published: (2026)

Reply: Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More Effective? A Three‐Arm, Multicenter Randomized Clinical Trial
by: Xinlu Ren, et al.
Published: (2025)

Helicobacter pylori Eradication in Older Individuals: A Systematic Review and Meta‐Analysis
by: Sun Jae Moon, et al.
Published: (2025)

Correction to “Long‐Term Effects of Fecal Microbiota Transplantation on Gut Microbiota After Helicobacter pylori Eradication With Bismuth Quadruple Therapy: A Randomized Controlled Trial”
Published: (2024)

Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial
by: Ka Shing Cheung, et al.
Published: (2024)

Authors' Reply to the Letter on “Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More Effective? A Three‐Arm, Multicenter Randomized Clinical Trial”
by: Zhengchen Yu, et al.
Published: (2025)

Efficacy of Tegoprazan‐Containing Sequential Eradication Treatment Compared to Esomeprazole‐Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicrobial Resistance: A Prospective, Randomized, Single Tertiary Center Study
by: Jung Won Lee, et al.
Published: (2024)

Cost‐Effectiveness of Population‐Based Helicobacter pylori Screening With Eradication for Optimal Age of Implementation
by: Akiko Kowada
Published: (2024)

Comparative Efficacy and Safety of Potassium‐Competitive Acid Blockers and Proton Pump Inhibitors for First‐Line Helicobacter pylori Eradication Therapy: A Systematic Review and Network Meta‐Analysis
by: Mengling Ouyang, et al.
Published: (2024)

Long‐Term Effect of Helicobacter pylori Eradication on Gastric Atrophy and Intestinal Metaplasia After Endoscopic Resection of Gastric Neoplasm: A Follow‐Up of a Randomized Controlled Trial
by: Young‐Il Kim, et al.
Published: (2026)

Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis
by: Yuheng Zhang, et al.
Published: (2025)

Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐ EuReg )
by: Samuel J. Martínez‐Domínguez, et al.
Published: (2024)

Empirical Rescue Eradication Therapy for Helicobacter pylori Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on H. pylori Management (Hp‐ BrazilReg )
by: B. S. F. Sanches, et al.
Published: (2025)

High‐Dose Dual Therapy Versus Bismuth‐Containing Quadruple Therapy as Rescue Treatment for Helicobacter pylori Infection: Systematic Review and Meta‐Analysis
by: Liang Zhang, et al.
Published: (2026)

Second‐ and Third‐Line Therapies for Helicobacter pylori Eradication in Slovenia: Data From 2013–2023 of the European Registry on H. pylori Management
by: Bojan Tepes, et al.
Published: (2025)

Non‐Bismuth Quadruple Concomitant Treatment for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis
by: Pablo Parra, et al.
Published: (2026)